Table 6.
Area of care | Process of care indicator | p-value | Pairwise comparison of models: AOR [95% CI] | ||
---|---|---|---|---|---|
Blended Capitation vs. FFS |
CHC vs. FFS |
Blended Capitation vs. CHC |
|||
Dyslipidemia | Lipid Profile | 0.60 | 1.1 [0.9-1.4] |
0.9 [0.7-1.3] |
1.2 [0.8-1.7] |
Lipid lowering drug | 0.24 | 0.8 [0.5-1.3] |
0.7 [0.4-1.0] |
1.2 [0.7-2.1] |
|
Diabetes | 2 HbA1c tests | 0.01* | 1.5 [1.1-2.3] |
2.4† [1.4-4.2] |
0.6 [0.3-1.2] |
Chronic Kidney Disease | eGFR | 0.90 | 1.2 [0.6-2.3] |
1.1 [0.4-3.2] |
1.1 [0.3-3.9] |
Hypertension | 2 Blood Pressures | 0.73 | 1.0 [0.6-1.5] |
1.2 [0.7-1.8] |
0.9 [0.5-1.3] |
Antihypertensive drug | 0.25 | 0.7 [0.4-1.0] |
0.9 [0.5-1.3] |
0.8 [0.5-1.4] |
|
Waist Circumference | Waist Circumference (WC) | 0.007* | 3.7 † [1.8-7.8] |
2.0 [1.0-4.2] |
1.8 [0.8-4.0] |
Smoking advice | 0.13 | 1.6 [1.0-2.6] |
1.5 [0.8-2.9] |
1.0 [0.5-2.1] |
|
Smoking Cessation | Smoking Program | 0.25 | 2.7 [0.8-9.2] |
1.1 [0.4-2.6] |
2.6 [0.9-7.3] |
Smoking drug therapy | 0.04* | 1.5 [0.9-2.5] |
0.6 [0.3-1.1] |
2.4 † [1.3-4.6] |
Adjusted for age, sex, rurality, number of cardiovascular-related comorbidities, and year of data collection
* p < 0.05: Indicates that payment model has a significant effect on the delivery of the specified indicator
† p < 0.017: p-value limit for between group comparisons was corrected using a Bonferroni correction factor
AOR = Adjusted Odds Ratio, CI = 95% confidence interval on odds ratio